Company Profile

SimulConsult Inc
Profile last edited on: 3/24/20      CAGE: 5TPU5      UEI: SY9MCUG98L17

Business Identifier: Decision support system for clinical diagnosis and bioinformatics
Year Founded
2008
First Award
2012
Latest Award
2018
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

27 Crafts Road Suite 101
Chestnut Hill, MA 02467
   (617) 879-1670
   contact2016@simulconsult.com
   www.simulconsult.com
Location: Single
Congr. District: 04
County: Norfolk

Public Profile

SimulConsult's medical decision support software allows doctors and other medical professionals to combine clinical and laboratory findings and get a "simultaneous consult" about diagnosis. The software suggests diagnoses and also identifies other findings that will be most useful in reaching a diagnosis. The software uses a statistical pattern-matching approach that takes into account the age of onset and offset of the findings in each disease. This information comes from a large peer-reviewed community of experts, assembled in a manner similar to information in journals. Healthcare professionals can use the software to help think through a particular case and can also contribute material for others to use such as descriptions of findings in diseases. For example, a doctor who has just reviewed an area for a published article can add the details of the clinical description material to the database, referenced to the article. The result: contributors help people make diagnoses and find their published articles at the same time. Benefits of using the software include: Reach the differential faster and more effectively, while saving time and increasing diagnostic quality, with greater confidence in recognizing atypical presentations of a common diseases and uncommon diseases, ensuring they have been fully factored in to making the diagnosis. Automatically document medical necessity for expensive tests. Get help with pay-for-performance, by focusing on the most relevant clinical findings and tests, with automatic documentation of your workup.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2018 2 NIH $2,650,280
Project Title: Empowering Physicians with Evidence-Based Decision Support for Pediatric Rheumato
2015 2 NIH $1,720,372
Project Title: Automated Genome-Phenome Analysis

Key People / Management

  Lynn K Feldman -- Chief Executive Officer

  Rick Berenson -- Chief Financial Officer

  David Feldman -- CTO

  Michael M Segal -- Founder, Chairman and Chief Scientist.